Introduction
In this lecture, Prof. Ali Abdullah Sultan along with Prof. Thomas Forst and Prof. A. Ramachandran and will share their experience with GLP-1 receptor agonists to translate it into useful clinical practices for healthcare providers in Saudi Arabia.
Objectives
1. To be able to translate best practices from around the world into clinical practices here in Saudi Arabia.
2. To provide a different perspective on Diabetes management from clinical experience to Real-World Evidence.
3. To present real clinical cases from the practice.
This Course For :
Physician
( Cardiology , Endocrinology & Metabolism , Family Medicine , Internal Medicine , Nephrology )
Resident / Fellow
( Cardiology , Endocrinology & Metabolism , Family Medicine , Internal Medicine , Nephrology )
Speaker
Dr. Ali Abdullah Sultan
Senior Consultant Endocrinologist and Deputy Chairman of Internal medicine
Director of the Diabetes Center at the International Medical Center in Jeddah, KSA
Prof. A. Ramachandran
President of “India Diabetes Research Foundation (IDRF)” and Chairman of Dr. A. Ramachandran's Diabetes Hospitals
Prof. Thomas Andreas Forst
Chief Medical Officer, Clinical Research Services Andernach
Germany
Sponsored by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
09 Nov 2021 To 16 Nov 2021 -
08:00 PM To 11:59 PM 
Certificate Available 
Online Recorded
- 493
Add to Calendar
11/09/2021 08:00 PM
11/16/2021 11:59 PM
Asia/ Riyadh
Translating GLP-1 Receptor Agonists into T2DM Clinical Practice
Translating GLP-1 Receptor Agonists into T2DM Clinical Practice
https://medicalacademy.org/portal/event/view/1612
